Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jan:102:106741.
doi: 10.1016/j.ultsonch.2023.106741. Epub 2023 Dec 23.

Recent developments using malononitrile in ultrasound-assisted multicomponent synthesis of heterocycles

Affiliations
Review

Recent developments using malononitrile in ultrasound-assisted multicomponent synthesis of heterocycles

Ramin Javahershenas et al. Ultrason Sonochem. 2024 Jan.

Abstract

Ultrasonic irradiation serves as a vigorous and environmentally sustainable approach for augmenting multicomponent reactions (MCRs), offering benefits such as thermal enhancement, agitation, and activation, among others. Malononitrile emerges as a versatile reagent in this context, participating in a myriad of MCRs to produce structurally diverse heterocyclic frameworks. This review encapsulates the critical role of malononitrile in the sonochemical multicomponent synthesis of these heterocyclic structures. The paper further delves into the biochemical and pharmacological implications of these heterocycles, elucidating their reaction mechanisms as well as delineating the method's scope and limitations. We furnish an overview of the merits and challenges inherent to this synthetic approach and offer insights for potential avenues in future research.

Keywords: Heterocycles; Malononitrile; Multicomponent reactions; Sonochemistry; Synthesis; Ultrasound.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

None
Graphical abstract
Fig. 1
Fig. 1
Sonic frequencies.
Fig. 2
Fig. 2
General application of ultrasound.
Fig. 3
Fig. 3
Historical background of ultrasound.
Fig. 4
Fig. 4
Classification of sonosynthesis.
Fig. 5
Fig. 5
Some applications of sonosynthesis.
Fig. 6
Fig. 6
Schematic of acoustic cavitation.
Scheme 1
Scheme 1
Synthesis of highly functionalized seleno-1,4-dihydropyridines.
Scheme 2
Scheme 2
Synthesis of polyfunctionalized hexahydroquinolines.
Scheme 3
Scheme 3
Synthesis of polysubstituted 1,4-dihydropyridines.
Scheme 4
Scheme 4
Synthesis of 2-amino-5-oxo-4-aryl-5H-chromeno[4,3-b]pyridin-3-yl cyanides.
Scheme 5
Scheme 5
The proposed mechanism for the formation of 2-amino-5-oxo-4-aryl-5H-chromeno[4,3-b]pyridin-3-yl cyanides.
Scheme 6
Scheme 6
Synthesis of polyfunctionalized pyridine-annulated heterocyclic compounds.
Scheme 7
Scheme 7
Synthesis of 2-amino-3-cyanopyridine derivatives.
Scheme 8
Scheme 8
Synthesis of 2-amino-4-(hetero)aryl-3,5-dicarbonitrile-6-sulfanylpyridines.
Scheme 9
Scheme 9
Synthesis of thiadiazolo(3,2-α)pyrimidine-6-carbonitrile derivatives.
Scheme 10
Scheme 10
Synthesis of benzopyranopyrimidines.
Scheme 11
Scheme 11
Synthesis of 5-pyrimidinecarbonitriles.
Scheme 12
Scheme 12
Synthesis of imidazopyrimidines.
Scheme 13
Scheme 13
Plausible mechanism for s-Fe3O4 catalyzed synthesis of imidazopyrimidine.
Scheme 14
Scheme 14
Synthesis of imidazo[1,2-a]pyridine-6-carbonitrile derivatives.
Scheme 15
Scheme 15
Synthesis of benzo, thiazolo[3,2-a]pyrimidine derivatives.
Scheme 16
Scheme 16
Synthesis of 5-thioxopyridopyrimidine derivatives.
Scheme 17
Scheme 17
Synthesis of pyrano-chromene and benzopyrano-chromene derivatives.
Scheme 18
Scheme 18
Synthesis of a series of dihydropyrano[3,2-d], dioxin heterocycles.
Scheme 19
Scheme 19
Synthesis of pyrano[3,2-b]pyrans.
Scheme 20
Scheme 20
Synthesis of tetrahydrobenzo[b]pyran derivatives.
Scheme 21
Scheme 21
Synthesis of pyrano[2,3‐d]pyrimidine derivatives.
Scheme 22
Scheme 22
Synthesis of benzo[a]pyrano-[2,3-c]phenazine compounds.
Scheme 23
Scheme 23
Ultrasound-assisted synthesis of diverse 2-amino-4H-chromenes.
Scheme 24
Scheme 24
Synthesis of a wide variety of pyran derivatives.
Scheme 25
Scheme 25
Synthesis of tetrahydrobenzo[b]pyrans and 2-amino-7-hydroxy-4H-chromenes.
Scheme 26
Scheme 26
Synthesis of pyrano[2,3-d] pyrimidine diones derivatives.
Scheme 27
Scheme 27
Synthesis of 5-amino-8-oxo-7-phenyl-5,6,7,8 dihydropyrano[2′,3′,4,5]pyrido[3,2,1-jk]carbazol-6-carbonitriles.
Scheme 28
Scheme 28
Synthesis of tetrahydro-4H-benzo[b]pyrans and dihydropyrano[3,2-c]chromenes.
Scheme 29
Scheme 29
Synthesis of pyrano[3,2-b]pyran derivatives.
Scheme 30
Scheme 30
Synthesis of pyrano[2,3-d]pyrimidine derivatives, pyrano[3,2-b]pyran derivatives, and chromeno[2,3-d]pyrimidine derivatives.
Scheme 31
Scheme 31
Synthesis of pyrano[3,2-c]chromenes and tetrahydropyrano[3,2-b]pyrans.
Scheme 32
Scheme 32
Synthesis of polyfunctionalized pyran derivatives.
Scheme 33
Scheme 33
Synthesize 4H-pyrans.
Scheme 34
Scheme 34
Synthesis of pyrano[3,2-b]pyran and 7-tosyl-4,7-dihydropyrano[2,3-e]indole derivatives.
Scheme 35
Scheme 35
Synthesis of 4H-chromene-3-carbonitrile derivatives.
Scheme 36
Scheme 36
Synthesis of dihydropyrano[3,2-b]pyrans.
Scheme 37
Scheme 37
Synthesis of 2-amino-4H-pyranoquinoline frameworks.
Scheme 38
Scheme 38
Synthesis of 2-Amino-3-cyano-4H-chromene frameworks.
Scheme 39
Scheme 39
Synthesis of amino substituted-2,4-dihydro-pyrano[3,2-b]pyran-3-carbonitrile derivatives.
Scheme 40
Scheme 40
Synthesis of 1,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile derivatives, 5-thioxo-pyranopyrimidine, and 5-thioxopyridopyrimidine systems.
Scheme 41
Scheme 41
Synthesis of tetrahydrobenzo[b]pyran derivatives.
Scheme 42
Scheme 42
Synthesis of pyrano[2,3-d]pyrimidine-2,4(3H)-dione derivatives.
Scheme 43
Scheme 43
Synthesis of pyrano-pyrazolone derivatives.
Scheme 44
Scheme 44
Plausible strategy for synthesizing pyranopyrazolones.
Scheme 45
Scheme 45
Synthesis of pyranopyrazoles.
Scheme 46
Scheme 46
Synthesis of pyrano[2,3-c]pyrazoles-3-carboxylate derivatives.
Scheme 47
Scheme 47
Synthesis of dihydropyrano[2,3-c]pyrazole derivatives.
Scheme 48
Scheme 48
Synthesis of substituted pyrano[2,3-c]pyrazole-5-carbonitrile scaffolds.
Scheme 49
Scheme 49
Synthesis of series of dihydropyrano [2,3-c]pyrazoles.
Scheme 50
Scheme 50
Synthesized pyranopyrazole derivatives.
Scheme 51
Scheme 51
Synthesized tetrahydro-6H-isothiochromene-6,6,8-tricarbonitrile derivatives.
Scheme 52
Scheme 52
Synthesis of derivatives of thiopyrano[4,3-b]pyran structures.
Scheme 53
Scheme 53
Plausible mechanism for synthesis of thiopyrano[4,3-b]pyran structures.
Scheme 54
Scheme 54
Synthesis of spiro[indoline-3,4′-pyrano[2,3-c]pyrazole] derivatives.
Scheme 55
Scheme 55
Synthesis of Spiro[2-amino-4H-pyran-oxindole]s.
Scheme 56
Scheme 56
Synthesis of spirooxindole derivatives.
Scheme 57
Scheme 57
Synthesis of spiro[substituted-1,4′-pyrano[2,3-c]pyrazoles.
Scheme 58
Scheme 58
Synthesis of spirooxindole derivatives.
Scheme 59
Scheme 59
The plausible mechanism of synthesis of Spiro oxindole.
Scheme 60
Scheme 60
Synthesis of Spiro oxindoles.
Scheme 61
Scheme 61
Synthesis of spiro[indoline-3,4′-pyrano[2,3-c]pyrazole derivatives.
Scheme 62
Scheme 62
Synthesis of spiropyrano[2,3-c]pyrazole carboxylate derivatives and Spiro[indoline-3,4′-pyridine] derivatives.
Scheme 63
Scheme 63
Synthesis of spiro-[indeno[1,2-b]quinoxaline-11,4′-pyrano[3,2-b]pyran].
Scheme 64
Scheme 64
Synthesis of spirooxindole derivatives.
Scheme 65
Scheme 65
Synthesis of highly substituted pyrazole derivatives.
Scheme 66
Scheme 66
Plausible mechanism for synthesizing pyrazole derivatives.
Scheme 67
Scheme 67
Synthesis of bis(indole) derivatives.
Scheme 68
Scheme 68
Synthesis of 3-substituted indole derivatives.

References

    1. Kerru N., Gummidi L., Maddila S., Gangu K.K., Jonnalagadda S.B. A review on recent advances in nitrogen-containing molecules and their biological applications. Molecules. 2020;25:1909. doi: 10.3390/molecules25081909. - DOI - PMC - PubMed
    1. Taylor A.P., Robinson R.P., Fobian Y.M., Blakemore D.C., Jones L.H., Fadeyi O. Modern advances in heterocyclic chemistry in drug discovery. Org. Biomol. Chem. 2016;14:6611–6637. - PubMed
    1. Zhang T.Y. The evolving landscape of heterocycles in drugs and drug candidates In Advances in Heterocyclic Chemistry. Academic Press. 2017;121:1–12. doi: 10.1016/bs.aihch.2016.05.001. - DOI
    1. Jampilek J. Heterocycles in medicinal chemistry. Molecules. 2019;24:3839. doi: 10.3390/molecules24213839. - DOI - PMC - PubMed
    1. Baumann M., Baxendale I.R. An overview of the synthetic routes to the best selling drugs containing 6-membered heterocycles. Beilstein J. Org. Chem. 2013;9:2265–2319. doi: 10.3762/bjoc.9.265. - DOI - PMC - PubMed

LinkOut - more resources